Table 1

Outcome of adolescents and young adults with type 2 diabetes after bariatric surgery

Authorn (b)n (f)Age (years)OperationBMI (b)Follow-upOutcomeComments
Messiah et al. (38)6518.5 (11–19)*AGB46 kg/m2*1 year59% improvementDiabetes outcomes reported as part of larger AGB series (n = 436). Data from 65% of all AGB patients in the larger series were missing at 1 year. Specific loss to follow-up and definitions for change in diabetes status (or improvement) was not provided.
Messiah et al. (38)6718.5 (11–19)*RYGB51 kg/m2*1 year79% improvementDiabetes outcomes reported as part of larger RYGB series (n = 454). Data from 76% of all RYGB patients in the larger series were missing at 1 year. Specific loss to follow-up and definitions for change in diabetes status (or improvement) was not provided.
Inge et al. (43)11917.8 (14–21)RYGB50 kg/m21 year88% remissionAnalysis contains only those with diabetes. BMI decreased by 33% over 1 year. Remission defined as HbA1c <6.5% (or FBG <126 mg/dL) and off of diabetes medications. Nine of 11 patients had sufficient biochemical and medication use data at 1 year to score remission.
Inge et al. (2)231817 (13–19)*RYGB54 kg/m2*3 years94% remissionDiabetes outcomes reported as part of larger series. Remission defined as HbA1c <6.5% (or FBG <126 mg/dL) and off of medications.
Inge et al. (2)6217 (13–19)*VSG50 kg/m2*3 years68% remissionDiabetes outcomes reported as part of larger series. Remission defined as HbA1c <6.5% (or FBG <126 mg/dL) and off of medications.
Alqahtani et al. (39)525214.4 (4.9–21)*VSG48 kg/m2*3 years89% remissionDiabetes outcomes reported as part of larger series. Remission defined as HbA1c <6.5% (or FBG <126 mg/dL) and off of medications.
Alqahtani et al. (37)111111.2VSG45 kg/m25 years100% remissionDiabetes outcomes reported as part of larger series. Remission defined as HbA1c <6.5% (or FBG <126 mg/dL) and off of medications.
  • AGB, adjustable gastric band; BMI (b), BMI at baseline; FBG, fasting blood glucose; n (b), number in sample at baseline; n (f), number in sample at final time point; RYGB, Roux-en-Y gastric bypass; VSG, vertical sleeve gastrectomy.

  • * Data derived from the larger series in the analysis and is not specific to the diabetes subpopulation.

  • Remission data were modeled, taking into account the influence of missing data.